Literature DB >> 2540221

Occupancy of platelet receptors for platelet-activating factor in patients with septicemia.

F Lopez Diez1, M L Nieto, S Fernandez-Gallardo, M A Gijon, M Sanchez Crespo.   

Abstract

The possible involvement of platelet-activating factor (PAF) in the pathogenesis of endotoxemia, was investigated by using a binding assay to patients' platelets, complemented with the extraction and chemical characterization of PAF obtained from patients' platelets. Platelets from 12 human volunteers had 281 +/- 63 freely accessible high affinity binding sites (PAF-receptors) per platelet; whereas this number was of 49 +/- 37 PAF-receptors per platelet, n = 14 samples, P less than 0.01, in a group of 13 patients with positive blood culture. A group of patients with respiratory or cardiovascular disturbances and negative blood culture had 253 +/- 74, accessible receptors per platelet (n = 19 samples from 16 patients, P less than 0.01 as compared to septic patients, which was not significantly different when compared to control individuals). Patients with sepsis possessed significant amounts of PAF associated to their platelets, whereas this mediator could not be isolated from platelets of patients with respiratory or cardiovascular disturbances and negative blood culture, nor from platelets of control individuals. PAF was also assayed in whole blood samples and found at high concentrations in sepsis patients. These data indicate that occupancy of PAF receptors in combination with high amounts of platelet-associated PAF, is a common finding in patients with sepsis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2540221      PMCID: PMC303883          DOI: 10.1172/JCI114074

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Association of platelet-activating factor with primary acquired cold urticaria.

Authors:  K E Grandel; R S Farr; A A Wanderer; T C Eisenstadt; S I Wasserman
Journal:  N Engl J Med       Date:  1985-08-15       Impact factor: 91.245

2.  Is platelet activating factor (PAF) a mediator of endotoxin shock?

Authors:  Z Terashita; Y Imura; K Nishikawa; S Sumida
Journal:  Eur J Pharmacol       Date:  1985-02-26       Impact factor: 4.432

3.  Specific binding sites for platelet activating factor in human lung tissues.

Authors:  S B Hwang; M H Lam; T Y Shen
Journal:  Biochem Biophys Res Commun       Date:  1985-04-30       Impact factor: 3.575

4.  Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate.

Authors:  T M McIntyre; G A Zimmerman; K Satoh; S M Prescott
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Platelet-activating factor and the release of a platelet-derived coronary artery vasodilator substance in the canine.

Authors:  C V Jackson; W A Schumacher; S L Kunkel; E M Driscoll; B R Lucchesi
Journal:  Circ Res       Date:  1986-02       Impact factor: 17.367

6.  Inhibition of binding of the platelet-activating factor AGEPC to platelets by the AGEPC analog rac-3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl 2-thiazolioethyl phosphate (CV-3988).

Authors:  F H Valone
Journal:  Biochem Biophys Res Commun       Date:  1985-01-16       Impact factor: 3.575

7.  Interference of BN 52021, a PAF-acether antagonist, with endotoxin-induced hypotension in the guinea-pig.

Authors:  S Adnot; J Lefort; V Lagente; P Braquet; B B Vargaftig
Journal:  Pharmacol Res Commun       Date:  1986-08

8.  Characteristics of the binding of platelet-activating factor to platelets of different animal species.

Authors:  P Iñarrea; J Gomez-Cambronero; M Nieto; M S Crespo
Journal:  Eur J Pharmacol       Date:  1984-10-15       Impact factor: 4.432

9.  Synthesis of PAF-acether and blood volume changes in gram-negative sepsis.

Authors:  P Iñarrea; J Gomez-Cambronero; J Pascual; M C Ponte; L Hernando; M Sánchez-Crespo
Journal:  Immunopharmacology       Date:  1985-02

10.  Effects of the platelet-activating factor antagonist BN 52021 on the hemodynamics of rats with experimental cirrhosis of the liver.

Authors:  L M Villamediana; E Sanz; S Fernandez-Gallardo; C Caramelo; M Sanchez Crespo; P Braquet; J M Lopez-Novoa
Journal:  Life Sci       Date:  1986-07-21       Impact factor: 5.037

View more
  17 in total

1.  Effect of a selective PAF antagonist SM-10661 ((+/-)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one HCl) on experimental disseminated intravascular coagulation (DIC).

Authors:  N Imanishi; Y Komuro; S Morooka
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

Review 2.  Amicus or adversary: platelets in lung biology, acute injury, and inflammation.

Authors:  Fernando A Bozza; Amrapali M Shah; Andrew S Weyrich; Guy A Zimmerman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-21       Impact factor: 6.914

3.  The role of platelet-activating factor and peptidoleukotrienes in the vascular changes of rat passive anaphylaxis.

Authors:  S Fernández-Gallardo; M A Gijón; C García; V Furio; F T Liu; M Sánchez Crespo
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

4.  Are soluble factors relevant for polymorphonuclear leukocyte dysregulation in septicemia?

Authors:  C Wenisch; W Graninger
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

Review 5.  Cardiac dysfunction in sepsis: new theories and clinical implications.

Authors:  R M Grocott-Mason; A M Shah
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

Review 6.  Platelet-activating factor: receptors and signal transduction.

Authors:  W Chao; M S Olson
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

7.  Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.

Authors:  S J De Kimpe; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

8.  Platelet-activating factor and phospholipase A2 in patients with septic shock and trauma.

Authors:  J Sörensen; B Kald; C Tagesson; M Lindahl
Journal:  Intensive Care Med       Date:  1994-11       Impact factor: 17.440

9.  Bacteria induce release of platelet-activating factor (PAF) from polymorphonuclear neutrophil granulocytes: possible role for PAF in pathogenesis of experimentally induced bacterial pneumonia.

Authors:  A Makristathis; F Stauffer; S M Feistauer; A Georgopoulos
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates.

Authors:  Christian C Yost; Mark J Cody; Estelle S Harris; Nathan L Thornton; Alison M McInturff; Mark L Martinez; Nancy B Chandler; Christopher K Rodesch; Kurt H Albertine; Cathy A Petti; Andrew S Weyrich; Guy A Zimmerman
Journal:  Blood       Date:  2009-02-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.